3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response

BACKGROUND: The Her2 receptor is overexpressed in up to 25 % of breast cancers and is associated with a poor prognosis. Around half of Her2+ breast cancers also express the estrogen receptor and treatment for such tumours can involve both endocrine and Her2-targeted therapies. However, despite precl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangadhara, Sharath, Smith, Chris, Barrett-Lee, Peter, Hiscox, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888214/
https://www.ncbi.nlm.nih.gov/pubmed/27251376
http://dx.doi.org/10.1186/s12885-016-2377-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888214/
https://www.ncbi.nlm.nih.gov/pubmed/27251376
http://dx.doi.org/10.1186/s12885-016-2377-z

Ejemplares similares